223 related articles for article (PubMed ID: 21123177)
21. In vitro modification of human centromere protein CENP-C fragments by small ubiquitin-like modifier (SUMO) protein: definitive identification of the modification sites by tandem mass spectrometry analysis of the isopeptides.
Chung TL; Hsiao HH; Yeh YY; Shia HL; Chen YL; Liang PH; Wang AH; Khoo KH; Shoei-Lung Li S
J Biol Chem; 2004 Sep; 279(38):39653-62. PubMed ID: 15272016
[TBL] [Abstract][Full Text] [Related]
22. Characterization of a novel posttranslational modification in neuronal nitric oxide synthase by small ubiquitin-related modifier-1.
Watanabe M; Itoh K
Biochim Biophys Acta; 2011 Jul; 1814(7):900-7. PubMed ID: 21545853
[TBL] [Abstract][Full Text] [Related]
23. SUMOylation of RORalpha potentiates transcriptional activation function.
Hwang EJ; Lee JM; Jeong J; Park JH; Yang Y; Lim JS; Kim JH; Baek SH; Kim KI
Biochem Biophys Res Commun; 2009 Jan; 378(3):513-7. PubMed ID: 19041634
[TBL] [Abstract][Full Text] [Related]
24. The SUMO protease SENP6 is a direct regulator of PML nuclear bodies.
Hattersley N; Shen L; Jaffray EG; Hay RT
Mol Biol Cell; 2011 Jan; 22(1):78-90. PubMed ID: 21148299
[TBL] [Abstract][Full Text] [Related]
25. Swapping small ubiquitin-like modifier (SUMO) isoform specificity of SUMO proteases SENP6 and SENP7.
Alegre KO; Reverter D
J Biol Chem; 2011 Oct; 286(41):36142-36151. PubMed ID: 21878624
[TBL] [Abstract][Full Text] [Related]
26. Concepts and Methodologies to Study Protein SUMOylation: An Overview.
Matunis MJ; Rodriguez MS
Methods Mol Biol; 2016; 1475():3-22. PubMed ID: 27631794
[TBL] [Abstract][Full Text] [Related]
27. Ubiquitin-dependent proteolytic control of SUMO conjugates.
Uzunova K; Göttsche K; Miteva M; Weisshaar SR; Glanemann C; Schnellhardt M; Niessen M; Scheel H; Hofmann K; Johnson ES; Praefcke GJ; Dohmen RJ
J Biol Chem; 2007 Nov; 282(47):34167-75. PubMed ID: 17728242
[TBL] [Abstract][Full Text] [Related]
28. Dynamin interacts with members of the sumoylation machinery.
Mishra RK; Jatiani SS; Kumar A; Simhadri VR; Hosur RV; Mittal R
J Biol Chem; 2004 Jul; 279(30):31445-54. PubMed ID: 15123615
[TBL] [Abstract][Full Text] [Related]
29. Progress in the Discovery of Small Molecule Modulators of DeSUMOylation.
Chen S; Dong D; Xin W; Zhou H
Curr Issues Mol Biol; 2020; 35():17-34. PubMed ID: 31422931
[TBL] [Abstract][Full Text] [Related]
30. SUMO, hypoxia and the regulation of metabolism.
Agbor TA; Taylor CT
Biochem Soc Trans; 2008 Jun; 36(Pt 3):445-8. PubMed ID: 18481978
[TBL] [Abstract][Full Text] [Related]
31. Casein kinase-2-mediated phosphorylation increases the SUMO-dependent activity of the cytomegalovirus transactivator IE2.
Tripathi V; Chatterjee KS; Das R
J Biol Chem; 2019 Oct; 294(40):14546-14561. PubMed ID: 31371453
[TBL] [Abstract][Full Text] [Related]
32. The function of SUMOylation and its crucial roles in the development of neurological diseases.
Chen X; Zhang Y; Wang Q; Qin Y; Yang X; Xing Z; Shen Y; Wu H; Qi Y
FASEB J; 2021 Apr; 35(4):e21510. PubMed ID: 33710677
[TBL] [Abstract][Full Text] [Related]
33. Fifty shades of SUMO: its role in immunity and at the fulcrum of the growth-defence balance.
Verma V; Croley F; Sadanandom A
Mol Plant Pathol; 2018 Jun; 19(6):1537-1544. PubMed ID: 29024335
[TBL] [Abstract][Full Text] [Related]
34. Analysis of Histone Deacetylases Sumoylation by Immunoprecipitation Techniques.
Wagner T; Godmann M; Heinzel T
Methods Mol Biol; 2017; 1510():339-351. PubMed ID: 27761833
[TBL] [Abstract][Full Text] [Related]
35. A fluorescence-resonance-energy-transfer-based protease activity assay and its use to monitor paralog-specific small ubiquitin-like modifier processing.
Martin SF; Hattersley N; Samuel ID; Hay RT; Tatham MH
Anal Biochem; 2007 Apr; 363(1):83-90. PubMed ID: 17288980
[TBL] [Abstract][Full Text] [Related]
36. The ubiquitin-like modifier FAT10 interferes with SUMO activation.
Aichem A; Sailer C; Ryu S; Catone N; Stankovic-Valentin N; Schmidtke G; Melchior F; Stengel F; Groettrup M
Nat Commun; 2019 Oct; 10(1):4452. PubMed ID: 31575873
[TBL] [Abstract][Full Text] [Related]
37. Protein modification by SUMO.
Johnson ES
Annu Rev Biochem; 2004; 73():355-82. PubMed ID: 15189146
[TBL] [Abstract][Full Text] [Related]
38. Quantitative high-throughput screening identifies cytoprotective molecules that enhance SUMO conjugation via the inhibition of SUMO-specific protease (SENP)2.
Bernstock JD; Ye D; Smith JA; Lee YJ; Gessler FA; Yasgar A; Kouznetsova J; Jadhav A; Wang Z; Pluchino S; Zheng W; Simeonov A; Hallenbeck JM; Yang W
FASEB J; 2018 Mar; 32(3):1677-1691. PubMed ID: 29146736
[TBL] [Abstract][Full Text] [Related]
39. Distribution and paralogue specificity of mammalian deSUMOylating enzymes.
Kolli N; Mikolajczyk J; Drag M; Mukhopadhyay D; Moffatt N; Dasso M; Salvesen G; Wilkinson KD
Biochem J; 2010 Sep; 430(2):335-44. PubMed ID: 20590526
[TBL] [Abstract][Full Text] [Related]
40. The ubiquitin-proteasome system is a key component of the SUMO-2/3 cycle.
Schimmel J; Larsen KM; Matic I; van Hagen M; Cox J; Mann M; Andersen JS; Vertegaal AC
Mol Cell Proteomics; 2008 Nov; 7(11):2107-22. PubMed ID: 18565875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
